Shares of Amgen Inc. AMGN shed 1.42% to $293.54 Friday, on what proved to be an all-around dismal trading session for the ...

Romosozumab plus alendronate led to a greater improvement in bone strength than alendronate alone in postmenopausal women ...

Amgen's dividend yield remains attractive, with a moderate payout ratio and strong free cash flow. Click here to see why AMGN ...

What Happened: Grygiel's recent move involves selling 1,589 shares of Amgen. This information is documented in a Form 4 filing with the U.S. Securities and Exchange Commission on Friday. The total ...

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research.

Researchers discovered the importance of an enzyme that promotes growth of certain lung cancers. Lung cancer is a ...

The most significant addition was Envista Holdings Corp (NYSE:NVST), with 880,177 shares, accounting for 0.06% of the portfolio and a total value of $16.98 million. The second largest addition to the ...

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, ...

CHMP Adopts Positive Opinion for Aflibercept, Pegfilgrastim Biosimilars:  On January 30, 2025, the European Medicines Agency (EMA) Committee ...

On January 29, 2025, the U.S. Court of Appeals for the Federal Circuit affirmed the District Court for the Northern District of West ...

In a recent 8-K filing with the SEC, Tenaya Therapeutics, Inc. announced the appointment of Mr. Tomohiro Higa as the Interim Principal Accounting Officer (PAO), effective Thursday. Mr. Higa, who has ...

Palantir has burned bears and humbled Wall Street analysts who felt the stock was too rich at half the current price.